Connor Clark & Lunn Investment Management Ltd. Reduces Holdings in Acadia Healthcare Company, Inc. $ACHC

Connor Clark & Lunn Investment Management Ltd. reduced its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 11.1% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 208,054 shares of the company’s stock after selling 25,977 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Acadia Healthcare were worth $4,721,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Wolverine Asset Management LLC increased its position in Acadia Healthcare by 61.1% during the second quarter. Wolverine Asset Management LLC now owns 49,585 shares of the company’s stock worth $1,125,000 after buying an additional 18,812 shares during the period. Y Intercept Hong Kong Ltd grew its position in shares of Acadia Healthcare by 159.6% during the second quarter. Y Intercept Hong Kong Ltd now owns 71,159 shares of the company’s stock worth $1,615,000 after acquiring an additional 43,746 shares during the last quarter. Envestnet Asset Management Inc. increased its holdings in shares of Acadia Healthcare by 54.2% in the 2nd quarter. Envestnet Asset Management Inc. now owns 166,880 shares of the company’s stock valued at $3,786,000 after acquiring an additional 58,642 shares during the period. Oppenheimer Asset Management Inc. raised its position in Acadia Healthcare by 85.1% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 28,683 shares of the company’s stock valued at $651,000 after purchasing an additional 13,188 shares during the last quarter. Finally, AlphaQuest LLC boosted its stake in Acadia Healthcare by 57.4% during the 2nd quarter. AlphaQuest LLC now owns 11,238 shares of the company’s stock worth $255,000 after purchasing an additional 4,096 shares during the period.

Analysts Set New Price Targets

A number of research firms have commented on ACHC. Raymond James Financial set a $22.00 price objective on shares of Acadia Healthcare in a research note on Friday, November 7th. Guggenheim dropped their price target on Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating on the stock in a research report on Monday. Mizuho decreased their price objective on Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating for the company in a research report on Wednesday, August 13th. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, October 8th. Finally, Cowen reiterated a “buy” rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. Eight investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Acadia Healthcare currently has an average rating of “Moderate Buy” and an average target price of $32.82.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $16.08 on Friday. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. The stock has a 50 day simple moving average of $22.87 and a 200-day simple moving average of $22.67. The company has a market cap of $1.48 billion, a price-to-earnings ratio of 10.65, a price-to-earnings-growth ratio of 4.56 and a beta of 0.97. Acadia Healthcare Company, Inc. has a 12-month low of $15.98 and a 12-month high of $47.08.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. The firm had revenue of $851.57 million for the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.During the same quarter in the prior year, the company posted $0.91 earnings per share. Acadia Healthcare’s quarterly revenue was up 4.4% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. On average, equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.